Artificial Intelligence (AI) has emerged as a powerful tool in modern healthcare, transforming the way diseases are diagnosed and treated. In particular, AI has proven invaluable in the identification and validation of molecular biomarkers, which are key indicators of disease presence, progression, and response to treatment. Molecular biomarkers, which include genetic, epigenetic, proteomic, and metabolomic markers, play a critical role in early disease detection, prognosis, and therapeutic decision-making.
HTML PDF
Share this article
Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report